JP2007509978A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509978A5 JP2007509978A5 JP2006538354A JP2006538354A JP2007509978A5 JP 2007509978 A5 JP2007509978 A5 JP 2007509978A5 JP 2006538354 A JP2006538354 A JP 2006538354A JP 2006538354 A JP2006538354 A JP 2006538354A JP 2007509978 A5 JP2007509978 A5 JP 2007509978A5
- Authority
- JP
- Japan
- Prior art keywords
- moiety
- compound
- therapeutic drug
- composition
- tocopherol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- 229940126585 therapeutic drug Drugs 0.000 claims 19
- 239000000203 mixture Substances 0.000 claims 17
- 125000005647 linker group Chemical group 0.000 claims 13
- 239000000839 emulsion Substances 0.000 claims 9
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 claims 6
- 238000009472 formulation Methods 0.000 claims 6
- 239000012071 phase Substances 0.000 claims 6
- 230000001225 therapeutic effect Effects 0.000 claims 6
- 125000002640 tocopherol group Chemical group 0.000 claims 6
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 claims 5
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 5
- 229930012538 Paclitaxel Natural products 0.000 claims 5
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 claims 5
- 229960003668 docetaxel Drugs 0.000 claims 5
- 229960001592 paclitaxel Drugs 0.000 claims 5
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 5
- 229940123237 Taxane Drugs 0.000 claims 4
- -1 camptothecins Chemical class 0.000 claims 4
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 claims 4
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims 4
- 239000008346 aqueous phase Substances 0.000 claims 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 3
- 230000002062 proliferating effect Effects 0.000 claims 3
- 150000003900 succinic acid esters Chemical group 0.000 claims 3
- 229960001295 tocopherol Drugs 0.000 claims 3
- 229930003799 tocopherol Natural products 0.000 claims 3
- 235000010384 tocopherol Nutrition 0.000 claims 3
- 239000011732 tocopherol Substances 0.000 claims 3
- HAWSQZCWOQZXHI-FQEVSTJZSA-N 10-Hydroxycamptothecin Chemical compound C1=C(O)C=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 HAWSQZCWOQZXHI-FQEVSTJZSA-N 0.000 claims 2
- FJHBVJOVLFPMQE-QFIPXVFZSA-N 7-Ethyl-10-Hydroxy-Camptothecin Chemical compound C1=C(O)C=C2C(CC)=C(CN3C(C4=C([C@@](C(=O)OC4)(O)CC)C=C33)=O)C3=NC2=C1 FJHBVJOVLFPMQE-QFIPXVFZSA-N 0.000 claims 2
- HAWSQZCWOQZXHI-UHFFFAOYSA-N CPT-OH Natural products C1=C(O)C=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 HAWSQZCWOQZXHI-UHFFFAOYSA-N 0.000 claims 2
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 claims 2
- 229940127093 camptothecin Drugs 0.000 claims 2
- 239000000693 micelle Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51536403P | 2003-10-29 | 2003-10-29 | |
| US55613704P | 2004-03-24 | 2004-03-24 | |
| US55876204P | 2004-04-01 | 2004-04-01 | |
| US62165504P | 2004-10-26 | 2004-10-26 | |
| PCT/US2004/036127 WO2005042539A1 (en) | 2003-10-29 | 2004-10-29 | Tocopherol-modified therapeutic drug compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007509978A JP2007509978A (ja) | 2007-04-19 |
| JP2007509978A5 true JP2007509978A5 (enExample) | 2007-12-13 |
Family
ID=34557676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538354A Pending JP2007509978A (ja) | 2003-10-29 | 2004-10-29 | トコフェロール修飾治療薬化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US7223770B2 (enExample) |
| EP (1) | EP1682552B1 (enExample) |
| JP (1) | JP2007509978A (enExample) |
| KR (1) | KR20060110872A (enExample) |
| AT (1) | ATE472551T1 (enExample) |
| AU (1) | AU2004285037B2 (enExample) |
| BR (1) | BRPI0415858A (enExample) |
| CA (1) | CA2543722C (enExample) |
| DE (1) | DE602004027936D1 (enExample) |
| IL (1) | IL175158A0 (enExample) |
| TW (1) | TW200522978A (enExample) |
| WO (1) | WO2005042539A1 (enExample) |
Families Citing this family (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8557861B2 (en) * | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| ES2391775T3 (es) * | 2004-11-05 | 2012-11-29 | Samyang Biopharmaceuticals Corporation | Formulación farmacéutica para aumentar la solubilidad de compuestos de 10-hidroxicamptotecina en disolventes polares no acuosos |
| GT200500310A (es) | 2004-11-19 | 2006-06-19 | Compuestos organicos | |
| NZ595313A (en) | 2005-02-18 | 2013-03-28 | Abraxis Bioscience Llc | The Use Of Nanoparticles Comprising Rapamycin Or Taxane In The Treatment Of Proliferative Diseases |
| SA06270147B1 (ar) | 2005-06-09 | 2009-12-22 | نوفارتيس ايه جي | عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين |
| AU2016244292A1 (en) * | 2005-07-18 | 2016-11-03 | University Of Massachusetts Lowell | Compositions and methods for making and using nanoemulsions |
| JP5368793B2 (ja) | 2005-07-18 | 2013-12-18 | ユニバーシティ オブ マサチューセッツ ロウエル | ナノエマルジョンを製造および使用するための組成物および方法 |
| WO2007035311A2 (en) * | 2005-09-16 | 2007-03-29 | University Of Massachusetts Lowell | Anti-oxidant synergy formulation nanoemulsions to treat cancer |
| US7572610B2 (en) * | 2005-10-03 | 2009-08-11 | Biotechnology Research & Development Corporation | Methods of making compositions comprising a UV-Absorbing chromophore |
| US7727514B2 (en) * | 2005-10-03 | 2010-06-01 | Biotechnology Research & Development Corporation | Compositions comprising a UV-absorbing chromophore |
| US7744856B2 (en) * | 2005-10-03 | 2010-06-29 | Biotech Research And Development Corporation | Formulations with feruloyl glycerides and methods of preparation |
| US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
| PT3144013T (pt) | 2005-12-01 | 2019-02-07 | Univ Massachusetts Lowell | Nanoemulsões botulínicas |
| US7786134B2 (en) * | 2005-12-16 | 2010-08-31 | Sonus Pharmaceuticals, Inc. | Lipophilic anticancer drug compounds, compositions and related methods |
| CZ300305B6 (cs) * | 2005-12-20 | 2009-04-15 | Heaton, A. S. | Farmaceutická kompozice obsahující derivát taxanu se zlepšenou terapeutickou úcinností |
| US20070167422A1 (en) * | 2006-01-18 | 2007-07-19 | Yu Kwok S | Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin |
| TWI376239B (en) * | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| WO2008003090A2 (en) * | 2006-06-29 | 2008-01-03 | Biotech Research And Development Corporation | Formulations with feruloyl glycerides and methods of preparation |
| WO2008016664A2 (en) * | 2006-08-02 | 2008-02-07 | University Of Massachusetts Lowell | Compositions and methods for treating cancer with dacarbazine nanoemulsions |
| AU2007353340A1 (en) | 2006-12-01 | 2008-11-20 | Anterios, Inc. | Peptide nanoparticles and uses therefor |
| WO2008070538A2 (en) | 2006-12-01 | 2008-06-12 | Anterios, Inc. | Micellar nanoparticles comprising botulinum toxin |
| CA2688415C (en) | 2007-05-31 | 2015-11-10 | Anterios, Inc. | Nucleic acid nanoparticles and uses therefor |
| CA2686225A1 (en) * | 2007-06-22 | 2008-12-31 | Scidose Llc | Solubilized formulation of docetaxel without tween 80 |
| EP2222278B1 (en) | 2007-11-28 | 2015-04-08 | Celator Pharmaceuticals, Inc. | Improved taxane delivery system |
| BRPI0909185A2 (pt) * | 2008-03-20 | 2015-08-25 | Virun Inc | Derivado de vitamina e e seus usos |
| BRPI0909187A2 (pt) | 2008-03-20 | 2015-08-04 | Virun Inc | Emulsões incluindo tocoferol de derivados de peg |
| US7670894B2 (en) * | 2008-04-30 | 2010-03-02 | Intel Corporation | Selective high-k dielectric film deposition for semiconductor device |
| US20110212157A1 (en) * | 2008-06-26 | 2011-09-01 | Anterios, Inc. | Dermal delivery |
| WO2010124223A1 (en) * | 2009-04-23 | 2010-10-28 | First Tech International Limited | Anti-cancer tocotrienol analogues and associated methods |
| EP2473044B1 (en) * | 2009-09-01 | 2014-04-02 | First Tech International Limited | Tocotrienol compositions |
| US20110092579A1 (en) * | 2009-10-19 | 2011-04-21 | Scidose Llc | Solubilized formulation of docetaxel |
| US7772274B1 (en) | 2009-10-19 | 2010-08-10 | Scidose, Llc | Docetaxel formulations with lipoic acid |
| US8541465B2 (en) * | 2009-10-19 | 2013-09-24 | Scidose, Llc | Docetaxel formulations with lipoic acid and/or dihydrolipoic acid |
| US8912228B2 (en) | 2009-10-19 | 2014-12-16 | Scidose Llc | Docetaxel formulations with lipoic acid |
| WO2011097481A1 (en) * | 2010-02-05 | 2011-08-11 | First Tech International Limited | Tocotrienol esters |
| US20110200645A1 (en) * | 2010-02-18 | 2011-08-18 | Martek Biosciences Corporation | DHA Free Fatty Acid Emulsions |
| KR101622441B1 (ko) * | 2010-03-23 | 2016-05-18 | 버런, 아이엔씨. | 자당 지방산 에스테르를 포함하는 나노에멀전 |
| BR112012024590A2 (pt) | 2010-03-29 | 2016-05-31 | Abraxis Bioscience Inc | métodos de reforço da liberação de fármaco e da eficácia de agentes terapêuticos |
| RU2016119999A (ru) | 2010-03-29 | 2018-11-08 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечения онкологических заболеваний |
| JP6257324B2 (ja) | 2010-06-04 | 2018-01-10 | アブラクシス バイオサイエンス, エルエルシー | 膵臓がんの処置方法 |
| WO2011162802A1 (en) | 2010-06-21 | 2011-12-29 | Virun, Inc. | Compositions containing non-polar compounds |
| US9731025B2 (en) | 2010-08-20 | 2017-08-15 | National University Corporation Tokyo Medical And Dental University | Pharmaceutical composition for transcolonic absorption |
| US20120178813A1 (en) | 2011-01-12 | 2012-07-12 | Thetis Pharmaceuticals Llc | Lipid-lowering antidiabetic agent |
| CN102516258B (zh) * | 2011-11-11 | 2014-06-25 | 正大天晴药业集团股份有限公司 | 水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用 |
| EP2811847B1 (en) | 2012-02-10 | 2017-12-13 | Virun, Inc. | Beverage compositions containing non-polar compounds |
| CN102731519B (zh) * | 2012-06-26 | 2014-12-17 | 济南精合医药科技有限公司 | 用于抗肿瘤药物的对硝基芳甲氧基喜树碱缺氧激活前药 |
| CN102731518B (zh) * | 2012-06-26 | 2014-12-03 | 济南精合医药科技有限公司 | 用于抗肿瘤药物的邻硝基芳甲氧基喜树碱缺氧激活前药 |
| US8765811B2 (en) | 2012-07-10 | 2014-07-01 | Thetis Pharmaceuticals Llc | Tri-salt form of metformin |
| US9382187B2 (en) | 2012-07-10 | 2016-07-05 | Thetis Pharmaceuticals Llc | Tri-salt form of metformin |
| US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
| US20140314672A1 (en) * | 2013-04-06 | 2014-10-23 | Igdrasol, Inc. | Nanoparticle therapeutic agents, their formulations, and methods of their use |
| US20150147382A1 (en) * | 2013-09-23 | 2015-05-28 | Exir Nano Sina Company | Topical liposomal compositions for delivering hydrophobic drugs and methods preparing same |
| WO2015171516A1 (en) | 2014-05-05 | 2015-11-12 | Thetis Pharmaceuticals Llc | Compositions and methods relating to ionic salts of peptides |
| WO2015171924A2 (en) * | 2014-05-07 | 2015-11-12 | Cornell University | Inhibitors of fusion between viral and cell membranes as well as compositions and methods of using them |
| US9242008B2 (en) | 2014-06-18 | 2016-01-26 | Thetis Pharmaceuticals Llc | Mineral amino-acid complexes of fatty acids |
| CN107074884A (zh) | 2014-06-18 | 2017-08-18 | 西蒂斯制药有限责任公司 | 活性剂的矿物质氨基酸复合物 |
| US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
| US10071112B2 (en) | 2014-10-08 | 2018-09-11 | Epigenetics Pharma Llc | Vitamin E-nucleoside prodrugs |
| CN105777770B (zh) * | 2014-12-26 | 2018-05-25 | 中国人民解放军第二军医大学 | 一种饱和长链脂肪酸修饰的7-乙基-10-羟基喜树碱化合物及其长循环脂质体 |
| CN104800858B (zh) * | 2015-04-27 | 2017-11-21 | 中国医学科学院基础医学研究所 | Hsp90抑制肽偶联物及其在肿瘤治疗中的应用 |
| GB2550346B (en) * | 2016-05-13 | 2021-02-24 | Phytoceutical Ltd | Micelles |
| JP6906047B2 (ja) | 2016-06-03 | 2021-07-21 | テティス・ファーマシューティカルズ・エルエルシー | 特異的炎症収束性メディエーターの塩に関連する組成物及び方法 |
| CN110225975A (zh) | 2016-08-23 | 2019-09-10 | 阿库斯股份有限公司 | 用于治疗人受试者中非年龄相关的听力损害的组合物和方法 |
| JP2019535829A (ja) | 2016-11-21 | 2019-12-12 | エイリオン セラピューティクス, インコーポレイテッド | 大型薬剤の経皮送達 |
| GB201812972D0 (en) | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| GB201812980D0 (en) | 2018-08-09 | 2018-09-26 | Univ Oxford Innovation Ltd | Cell-penetrating peptides |
| EA202190799A1 (ru) * | 2018-09-17 | 2021-06-22 | Дзе Чилдрен'З Хоспитал Оф Филадельфия | Макромолекулярные пролекарства на полимерной основе |
| EP3890783A1 (en) * | 2018-12-07 | 2021-10-13 | Oxford University Innovation Limited | Linkers |
| EP4114958A1 (en) | 2020-02-21 | 2023-01-11 | Akouos, Inc. | Compositions and methods for treating non-age-associated hearing impairment in a human subject |
| CA3229030A1 (en) * | 2021-09-05 | 2023-03-09 | Yi-Wen Chu | Formulations with enhanced sn-38 solubility and oral absorption |
| MX2024003496A (es) | 2021-10-15 | 2024-04-05 | Kunshan Xinyunda Biotech Co Ltd | Composicion que contiene un farmaco antitumoral, metodo de preparacion y uso de este. |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1395994A (en) * | 1972-08-23 | 1975-05-29 | Delmar Chem | Tocopherol derivative processes for making it and pharmaceutical compositions containing it |
| GB1409612A (en) * | 1973-09-13 | 1975-10-08 | Ahrens G W | Phenylpropyl-d-alpha-tocopherol-succinate the method for making the same and preparations |
| WO1979000401A1 (fr) * | 1977-12-16 | 1979-07-12 | Nisshin Flour Milling Co | Agent anti-tumeur |
| JPS5484034A (en) * | 1977-12-16 | 1979-07-04 | Nisshin Flour Milling Co Ltd | Anti-tumor agent |
| US4665204A (en) * | 1985-06-27 | 1987-05-12 | Henkel Corporation | Diester derivatives of tocopherol |
| US5610180A (en) * | 1988-01-29 | 1997-03-11 | Virginia Commonwealth University | Ionizable congeners of aromatic and aliphatic alcohols as anti-leukemia agents |
| US5234695A (en) * | 1990-07-24 | 1993-08-10 | Eastman Kodak Company | Water dispersible vitamin E composition |
| WO1995011039A1 (de) | 1993-10-22 | 1995-04-27 | Hexal Pharma Gmbh | Pharmazeutische zusammensetzung mit cyclosporin a und alpha-tocopherol |
| GB9409778D0 (en) | 1994-05-16 | 1994-07-06 | Dumex Ltd As | Compositions |
| CA2148148A1 (en) * | 1994-05-20 | 1995-11-21 | Kazumi Ogata | Tocopherol derivatives |
| DE4423915A1 (de) * | 1994-07-07 | 1996-01-11 | Carl Heinrich Dr Weischer | Derivate des Salazosulfapyridins, deren Herstellung und Verwendung als Arzneimittel |
| US5858398A (en) * | 1994-11-03 | 1999-01-12 | Isomed Inc. | Microparticular pharmaceutical compositions |
| US5945409A (en) * | 1995-03-10 | 1999-08-31 | Wilson T. Crandall | Topical moisturizing composition and method |
| US5912078A (en) * | 1996-05-02 | 1999-06-15 | Milliken & Company | Lubricant finish for textiles |
| US5795909A (en) * | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
| ES2151277T3 (es) * | 1996-05-22 | 2000-12-16 | Protarga Inc | Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere. |
| US6576636B2 (en) * | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
| US5919815A (en) * | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
| US6258823B1 (en) * | 1996-07-12 | 2001-07-10 | Ariad Pharmaceuticals, Inc. | Materials and method for treating or preventing pathogenic fungal infection |
| US5891469A (en) * | 1997-04-02 | 1999-04-06 | Pharmos Corporation | Solid Coprecipitates for enhanced bioavailability of lipophilic substances |
| US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US6727280B2 (en) * | 1997-01-07 | 2004-04-27 | Sonus Pharmaceuticals, Inc. | Method for treating colorectal carcinoma using a taxane/tocopherol formulation |
| GB9715759D0 (en) * | 1997-07-26 | 1997-10-01 | Danbiosyst Uk | New emulsion formulations |
| US6545125B1 (en) * | 1997-11-18 | 2003-04-08 | Chugai Seiyaku Kabushiki Kaisha | Compounds with antitumor activity |
| US5917060A (en) * | 1997-12-17 | 1999-06-29 | Basf Aktiengesellschaft | Preparation of chromanyl derivatives |
| US6387882B1 (en) * | 1997-12-24 | 2002-05-14 | Senju Pharmaceutical Co., Ltd. | Vitamin E derivatives |
| US6086915A (en) * | 1998-04-01 | 2000-07-11 | Bioresponse L.L.C. | Compositions and methods of adjusting steroid hormone metabolism through phytochemicals |
| EP1115398B1 (en) * | 1998-09-23 | 2010-05-05 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| US6045826A (en) * | 1999-04-02 | 2000-04-04 | National Research Council Of Canada | Water-soluble compositions of bioactive lipophilic compounds |
| CA2373994A1 (en) * | 1999-05-24 | 2000-11-30 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| CA2394645A1 (en) * | 1999-06-11 | 2000-12-21 | Sydney Hyman | Image making medium |
| AU7719100A (en) * | 1999-09-27 | 2001-04-30 | Panayiotis Constantinides | Compositions of tocol-soluble therapeutics |
| US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
| WO2002076970A2 (en) * | 2001-03-23 | 2002-10-03 | Sonus Pharmaceuticals, Inc. | Tocopherol succinate derivatives and compositions |
| US6774116B2 (en) * | 2001-04-17 | 2004-08-10 | Cryolife, Inc. | Prodrugs via acylation with cinnamate |
| US6858227B1 (en) * | 2001-11-21 | 2005-02-22 | Sonus Pharmaceuticals, Inc. | Vitamin E conjugates |
| US6683194B2 (en) * | 2002-02-05 | 2004-01-27 | Sonus Pharmaceuticals, Inc. | Tocopherol derivatives |
-
2004
- 2004-10-29 KR KR1020067008232A patent/KR20060110872A/ko not_active Ceased
- 2004-10-29 EP EP04817489A patent/EP1682552B1/en not_active Expired - Lifetime
- 2004-10-29 AT AT04817489T patent/ATE472551T1/de not_active IP Right Cessation
- 2004-10-29 WO PCT/US2004/036127 patent/WO2005042539A1/en not_active Ceased
- 2004-10-29 DE DE602004027936T patent/DE602004027936D1/de not_active Expired - Lifetime
- 2004-10-29 TW TW093132975A patent/TW200522978A/zh unknown
- 2004-10-29 BR BRPI0415858-0A patent/BRPI0415858A/pt not_active IP Right Cessation
- 2004-10-29 JP JP2006538354A patent/JP2007509978A/ja active Pending
- 2004-10-29 AU AU2004285037A patent/AU2004285037B2/en not_active Ceased
- 2004-10-29 US US10/978,222 patent/US7223770B2/en not_active Expired - Fee Related
- 2004-10-29 CA CA2543722A patent/CA2543722C/en not_active Expired - Fee Related
-
2006
- 2006-04-25 IL IL175158A patent/IL175158A0/en unknown
- 2006-06-08 US US11/450,795 patent/US20060229359A1/en not_active Abandoned
-
2007
- 2007-03-22 US US11/690,005 patent/US20070207196A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007509978A5 (enExample) | ||
| JP2013503174A5 (enExample) | ||
| Beckers et al. | Natural, semisynthetic and synthetic microtubule inhibitors for cancer therapy | |
| CA2543722A1 (en) | Tocopherol-modified therapeutic drug compounds | |
| Zhang et al. | Polymeric micelles: nanocarriers for cancer-targeted drug delivery | |
| Ojima et al. | Tumor-specific novel taxoid− monoclonal antibody conjugates | |
| Rivera et al. | Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors | |
| JP2015501833A5 (enExample) | ||
| JP2014508804A5 (enExample) | ||
| JP2014511840A5 (enExample) | ||
| WO2014023081A1 (zh) | 青嵩素衍生物及其制法和应用 | |
| JP2005506298A5 (enExample) | ||
| US20040019088A1 (en) | Use of Epothilones in the treatment of brain diseases associated with proliferative processes | |
| CN1950376A (zh) | 莪术醇衍生物、含该衍生物的组合物及所述衍生物的制药用途 | |
| JP2012506443A5 (enExample) | ||
| JP2009541387A5 (enExample) | ||
| JPWO2020163823A5 (enExample) | ||
| JP2011517455A5 (enExample) | ||
| Ferlini et al. | New taxanes in development | |
| JP2004523478A5 (enExample) | ||
| Zhou et al. | EM012, a microtubule-interfering agent, inhibits the progression of multidrug-resistant human ovarian cancer both in cultured cells and in athymic nude mice | |
| JP2004509919A (ja) | 抗有糸分裂剤及び抗腫瘍剤としてのタキソイド接合体 | |
| Siddiqui-Jain et al. | Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization | |
| JP2003516994A5 (enExample) | ||
| JP2013518032A5 (enExample) |